A two-year placebo-controlled , double-blind study was conducted to ( 1 ) ascertain if high-dose , prolonged treatment with valacyclovir would be safe and ( 2 ) observe if valacyclovir would delay the progression of MS clinically or by magnetic resonance imaging ( MRI ) .
